Getwell Pharmaceuticals — Ifosfamide Exporter Profile
Indian Pharmaceutical Exporter · #3 for Ifosfamide · $296.0K export value · DGFT Verified
Getwell Pharmaceuticals is the #3 Indian exporter of Ifosfamide with $296.0K in export value and 39 verified shipments. Getwell Pharmaceuticals holds a 12.1% market share in Ifosfamide exports across 6 countries. The company exports 7 pharmaceutical products worth $1.5M across 3 therapeutic categories.
Getwell Pharmaceuticals — Ifosfamide Export Profile: Buyers & Destinations
Where Does Getwell Pharmaceuticals Export Ifosfamide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $234.5K | 20 | 79.2% |
| NEPAL | $39.8K | 5 | 13.4% |
| KENYA | $18.2K | 8 | 6.1% |
| MONGOLIA | $2.1K | 2 | 0.7% |
| KOREA,REPUBLIC OF | $1.4K | 2 | 0.5% |
| JAMAICA | $0 | 2 | 0.0% |
Getwell Pharmaceuticals exports Ifosfamide to 6 countries. The largest destination is PHILIPPINES accounting for 79.2% of Getwell Pharmaceuticals's Ifosfamide shipments, followed by NEPAL (13.4%) and KENYA (6.1%). These destinations reflect Getwell Pharmaceuticals's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ifosfamide from Getwell Pharmaceuticals?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AMBICA INTERNATIONAL CORPORATION | PHILIPPINES | $178.5K | 14 |
| AMBICA INTERNATIONAL CORPORATI | PHILIPPINES | $56.0K | 6 |
| VISION CARE INTERNATIONAL PVT. LTD. | NEPAL | $29.0K | 3 |
| M/S NAIROBI ENTERPRISES LTD. | KENYA | $16.2K | 7 |
| VISION CARE INTERNATIONAL PVT LTD | NEPAL | $10.7K | 2 |
| TSOMBO LLC | KOREA,REPUBLIC OF | $3.6K | 4 |
| MS NAIROBI ENTERPRISES LIMITED | KENYA | $2.0K | 1 |
| RECHARGED DISTRIBUTORS LIMITED | JAMAICA | $0 | 2 |
Getwell Pharmaceuticals supplies Ifosfamide to 8 buyers globally. The largest buyer is AMBICA INTERNATIONAL CORPORATION (PHILIPPINES), followed by AMBICA INTERNATIONAL CORPORATI (PHILIPPINES) and VISION CARE INTERNATIONAL PVT. LTD. (NEPAL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ifosfamide Export Value and How Much Does Getwell Pharmaceuticals Contribute?
India exported $1.7M worth of Ifosfamide through 732 shipments from 152 suppliers to 80 countries, serving 236 buyers globally. Getwell Pharmaceuticals contributes $296.0K to this total, accounting for 12.1% of India's Ifosfamide exports. Getwell Pharmaceuticals ships Ifosfamide to 6 countries through 8 buyers.
What Is the Average Shipment Value for Getwell Pharmaceuticals's Ifosfamide Exports?
Getwell Pharmaceuticals's average Ifosfamide shipment value is $7.6K per consignment, based on 39 shipments totaling $296.0K. The largest destination is PHILIPPINES (79.2% of Getwell Pharmaceuticals's Ifosfamide exports).
How Does Getwell Pharmaceuticals Compare to Other Indian Ifosfamide Exporters?
Getwell Pharmaceuticals ranks #3 among 152 Indian Ifosfamide exporters with a 12.1% market share. The top 3 exporters are VIVALIA REMEDIES PRIVATE LIMITED ($350.0K), UNITED BIOTECH PRIVATE LIMITED ($335.3K), GETWELL PHARMACEUTICALS ($296.0K). Getwell Pharmaceuticals processed 39 shipments to 6 destination countries.
What Ifosfamide Formulations Does Getwell Pharmaceuticals Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FOSFA-1G (IFOSFAMIDE FOR INJECTION USP) | $40.1K | 3 |
| FOSFA-2G (IFOSFAMIDE FOR INJECTION USP) | $38.7K | 3 |
| FOSFA -2G (IFOSFAMIDE FOR INJECTION USP | $29.0K | 3 |
| FOSFA-1G (IFOSFAMIDE FOR INJECTION USP), | $26.1K | 1 |
| FOSFA-2G IFOSFAMIDE FOR INJECTION USPBATCH NO. 3GIP11 MANUFACTURING .DT. 08/2023 EXP.DT. 07/2025 | $14.8K | 1 |
| FOSFA-1G IFOSFAMIDE FOR INJECTION USPBATCH NO. 3GIP09 MANUFACTURING .DT. 08/2023 EXP.DT. 07/2025 | $14.6K | 1 |
| FOSFA 1G (IFOSFAMIDE FOR INJECTION USP) | $14.4K | 1 |
| FOSFA-2G (IFOSFAMIDE FOR INJECTION USP)BATCH NO. 4GIP03 MFG.DT. 01/2024 EXP.DT. 12/2025NOS | $14.4K | 1 |
| FOSFA-1G (IFOSFAMIDE FOR INJECTION USP)BATCH NO. 4GIP01, MFG.DT. 01/2024, EXP.DT. 12/2025 | $14.1K | 1 |
| IFOSMIDE-2000 (IFOSFAMIDE FOR INJECTIONUSP)BATCH NO. 4GIP03, MFG.DT. 01/2024,EXP.DT. 12/2025 | $11.9K | 1 |
Getwell Pharmaceuticals exports 24 distinct Ifosfamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FOSFA-1G (IFOSFAMIDE FOR INJECTION USP) with 3 shipments worth $40.1K.
How Does Getwell Pharmaceuticals Compare to Nearest Ifosfamide Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | VIVALIA REMEDIES PRIVATE LIMITED | $350.0K | 7 | 1 | $50.0K |
| 2 | UNITED BIOTECH PRIVATE LIMITED | $335.3K | 68 | 12 | $4.9K |
| 3 | GETWELL PHARMACEUTICALS ★ | $296.0K | 39 | 6 | $7.6K |
| 4 | KWALITY PHARMACEUTICALS LIMITED | $177.0K | 9 | 3 | $19.7K |
| 5 | DAB PHARMA | $105.8K | 5 | 1 | $21.2K |
Getwell Pharmaceuticals ranks #3 among 152 Indian Ifosfamide exporters. Average shipment value of $7.6K compared to the market average of $11.1K. The closest competitors by value are VIVALIA REMEDIES PRIVATE LIMITED and UNITED BIOTECH PRIVATE LIMITED.
Which Indian Ports Ship Ifosfamide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 166 | 22.7% |
| SAHAR AIR | 136 | 18.6% |
| DELHI AIR CARGO ACC (INDEL4) | 130 | 17.8% |
| DELHI AIR | 94 | 12.8% |
| Bombay Air | 60 | 8.2% |
| AHEMDABAD AIR ACC (INAMD4) | 26 | 3.6% |
| Delhi Air | 18 | 2.5% |
| Bombay Air Cargo | 18 | 2.5% |
What Other Advanced Oncology Products Does Getwell Pharmaceuticals Export?
Getwell Pharmaceuticals also exports these advanced oncology products. Each links to the detailed product page.
About Getwell Pharmaceuticals
Getwell Pharmaceuticals exports 7 products worth $1.5M. Beyond Ifosfamide, top products include Protein, Doxorubicin, Cyclophosphamide, Etoposide, Fluorouracil. View the complete Getwell Pharmaceuticals profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ifosfamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ifosfamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Getwell Pharmaceuticals matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 39 individual customs records matching Getwell Pharmaceuticals exporting Ifosfamide, covering 24 formulations to 6 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 80+ countries, 236+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ifosfamide Export Data from Getwell Pharmaceuticals
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Getwell Pharmaceuticals's Ifosfamide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Getwell Pharmaceuticals
Full Company Profile →
7 products · $1.5M total trade · 3 categories
Ifosfamide Stats
Company Overview
Top Products by Getwell Pharmaceuticals
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Getwell Pharmaceuticals.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ifosfamide. For current shipment-level data, contact TransData Nexus.